5-MAPB: Difference between revisions

>Unity
m Clarity moved page Talk:5-MAPB to 5-MAPB without leaving a redirect
>Unity
No edit summary
Line 5: Line 5:
| ''[[ 5-MAPB/Summary|Summary sheet:  5-MAPB]]''
| ''[[ 5-MAPB/Summary|Summary sheet:  5-MAPB]]''
|}
|}
'''(1-(benzofuran-5-yl)-N-methylpropan-2-amine)''' (abbreviated '''5-MAPB''') is a synthetic [[Psychoactive class::entactogen]] of the substituted [[chemical class::benzofuran]] class of chemicals, which are known to produce [[euphoric|euphoria]], [[stimulant]] and mildly [[hallucinogen]]ic effects. These include such [[MDA]]-inspired substances as [[5-APB]], [[6-APB]] and [[5-EAPB]], among others. 5-MAPB is the N-methylated form of [[5-APB]], analogously to how [[MDMA]] is the N-methylated form of [[MDA]].
'''5-(2-methylaminopropyl)benzofuran''' (abbreviated '''5-MAPB''') is a synthetic [[Psychoactive class::entactogen]] of the substituted [[chemical class::benzofuran]] class of chemicals, which are known to produce physical and cognitive[[euphoria]], [[stimulant|stimulation]] and mildly [[hallucinogen]]ic effects. These include such [[MDA]]-inspired substances as [[5-APB]], [[6-APB]] and [[5-EAPB]], among others. 5-MAPB is the N-methylated form of [[5-APB]], analogously to how [[MDMA]] is the N-methylated form of [[MDA]].


This compound is known for its [[stimulating]], [[euphoria|euphoric]] and [[entactogen]]ic effects that is capable of acting a quasi-substitute for [[MDMA]] proper, which has resulted in its rise in popularity as a [[research chemical]] that is easily accessible through the use of online vendors. It has been sold as a [[designer drug]] since 2010.<ref>EMCDDA–Europol 2010 Annual Report on the implementation of Council Decision 2005/387/JHA | http://www.emcdda.europa.eu/publications/implementation-reports/2010</ref>
This compound is known for its [[stimulating]], [[euphoria|euphoric]] and [[entactogen]]ic effects that is capable of acting a quasi-substitute for [[MDMA]] proper, which has resulted in its rise in popularity as a [[research chemical]] that is easily accessible through the use of online vendors. It has been sold as a [[designer drug]] since 2010.<ref>EMCDDA–Europol 2010 Annual Report on the implementation of Council Decision 2005/387/JHA | http://www.emcdda.europa.eu/publications/implementation-reports/2010</ref>
Line 12: Line 12:


==Chemistry==
==Chemistry==
(1-(benzofuran-5-yl)-N-methylpropan-2-amine), or 5-MAPB, is a substituted [[benzofuran]] and [[phenethylamine]]. It is comprised of an N-methylated ethylamine chain and a furan ring attached to a central benzene ring. It can also be classified as a derivative of methamphetamine because the N-methylated ethylamine chain is alpha methylated in an analagous manner. Molecules of the amphetamine class contain a phenethylamine core featuring a phenyl ring bound to an amino (NH2) group through an ethyl chain with an additional methyl substitution at R<sub>α</sub>. The oxygen atom in the furan ring is placed at the 5 position, which generally constitutes more stimulating effects than when the oxygen is placed at the 6 position, which usually renders it more [[psychedelic]] in effect.
5-(2-methylaminopropyl)benzofuran, or 5-MAPB, is a substituted [[benzofuran]] and [[phenethylamine]]. It is comprised of an N-methylated ethylamine chain and a furan ring attached to a central benzene ring. It can also be classified as a derivative of methamphetamine because the N-methylated ethylamine chain is alpha methylated in an analagous manner. Molecules of the amphetamine class contain a phenethylamine core featuring a phenyl ring bound to an amino (NH2) group through an ethyl chain with an additional methyl substitution at R<sub>α</sub>. The oxygen atom in the furan ring is placed at the 5 position, which generally constitutes more stimulating effects than when the oxygen is placed at the 6 position, which usually renders it more [[psychedelic]] in effect.


==Pharmacology==
==Pharmacology==
Retrieved from "http://psy.st/wiki/5-MAPB"